133 related articles for article (PubMed ID: 37138462)
21. A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache.
Perrotta A; Biondi-Zoccai G; Saade W; Miraldi F; Morelli A; Marullo AG; Cavarretta E; Carnevale R; DE Falco E; Chimenti I; Sciarretta S; Frati P; Mamas MA; Ciardi S; Frati L; Frati G; Peruzzi M
Panminerva Med; 2021 Sep; 63(3):324-331. PubMed ID: 34738774
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
23. New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan.
Nakagawa N; Maruyama S; Kashihara N; Narita I; Isaka Y
Clin Exp Nephrol; 2022 Sep; 26(9):909-916. PubMed ID: 35569069
[TBL] [Abstract][Full Text] [Related]
24. Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports.
Garcia-Azorin D; Baykan B; Beghi E; Doheim MF; Fernandez-de-Las-Penas C; Gezegen H; Guekht A; Hoo FK; Santacatterina M; Sejvar J; Tamborska AA; Thakur KT; Westenberg E; Winkler AS; Frontera JA;
Cephalalgia; 2022 Oct; 42(11-12):1207-1217. PubMed ID: 35514199
[TBL] [Abstract][Full Text] [Related]
25. Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
Maruyama A; Sawa T; Teramukai S; Katoh N
J Infect Chemother; 2022 Jul; 28(7):934-942. PubMed ID: 35361536
[TBL] [Abstract][Full Text] [Related]
26. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
Kim JE; Park J; Min YG; Hong YH; Song TJ
J Peripher Nerv Syst; 2022 Sep; 27(3):206-214. PubMed ID: 35751472
[TBL] [Abstract][Full Text] [Related]
27. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
28. Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience.
Monte G; Papetti L; Ferilli MAN; Ursitti F; Moavero R; Sforza G; Panella E; Tarantino S; Checchi MP; Vigevano F; Palma P; Valeriani M
Front Immunol; 2023; 14():1106472. PubMed ID: 36761740
[TBL] [Abstract][Full Text] [Related]
29. Temporal association between COVID-19 vaccination and Raynaud's phenomenon: A case series.
Lisy M; Urban N; Brunner-Ziegler S; Weber B; Bauer WM; Dassler E; Koppensteiner R; Handisurya A
Hum Vaccin Immunother; 2023 Dec; 19(1):2199653. PubMed ID: 37067070
[TBL] [Abstract][Full Text] [Related]
30. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
See I; Su JR; Lale A; Woo EJ; Guh AY; Shimabukuro TT; Streiff MB; Rao AK; Wheeler AP; Beavers SF; Durbin AP; Edwards K; Miller E; Harrington TA; Mba-Jonas A; Nair N; Nguyen DT; Talaat KR; Urrutia VC; Walker SC; Creech CB; Clark TA; DeStefano F; Broder KR
JAMA; 2021 Jun; 325(24):2448-2456. PubMed ID: 33929487
[TBL] [Abstract][Full Text] [Related]
31. Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
Ruzicka M; Wurm S; Lindner L; Dreyling M; von Bergwelt-Baildon M; Boeck S; Giessen-Jung C; Milani V; Stemmler JH; Subklewe M; Weigert O; Spiekermann K
Infection; 2023 Feb; 51(1):231-238. PubMed ID: 36195695
[TBL] [Abstract][Full Text] [Related]
32. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 vaccine-related neurological complications.
Oonk NGM; Ettema AR; van Berghem H; de Klerk JJ; van der Vegt JPM; van der Meulen M
Neurol Sci; 2022 Apr; 43(4):2295-2297. PubMed ID: 35050428
[TBL] [Abstract][Full Text] [Related]
34. COVID-19 Vaccination and the Incidence of De Novo or Recurrent Rheumatoid Arthritis: A French and International (VigiBase) Signal Detection Study.
Prontskus V; Fresse A; Yelehe-Okouma M; Facile A; Pietri T; Simon C; Le Souder C; Beurrier M; Gillet P;
Clin Pharmacol Ther; 2023 May; 113(5):1107-1116. PubMed ID: 36752604
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 vaccination and Atypical hemolytic uremic syndrome.
Bouwmeester RN; Bormans EMG; Duineveld C; van Zuilen AD; van de Logt AE; Wetzels JFM; van de Kar NCAJ
Front Immunol; 2022; 13():1056153. PubMed ID: 36531998
[TBL] [Abstract][Full Text] [Related]
36. Assessment of Sudden Sensorineural Hearing Loss After COVID-19 Vaccination.
Formeister EJ; Wu MJ; Chari DA; Meek R; Rauch SD; Remenschneider AK; Quesnel AM; de Venecia R; Lee DJ; Chien W; Stewart CM; Galaiya D; Kozin ED; Sun DQ
JAMA Otolaryngol Head Neck Surg; 2022 Apr; 148(4):307-315. PubMed ID: 35201274
[TBL] [Abstract][Full Text] [Related]
37. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
[TBL] [Abstract][Full Text] [Related]
38. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers.
Song JY; Cheong HJ; Kim SR; Lee SE; Kim SH; Noh JY; Yoon YK; Choi WS; Park DW; Sohn JW; Kim WJ; Kim MJ
J Korean Med Sci; 2021 Apr; 36(15):e110. PubMed ID: 33876589
[TBL] [Abstract][Full Text] [Related]
39. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
40. Immune-mediated diseases after coronavirus disease 2019 vaccination: rare but important complication.
Zagorec N; Horvatić I; Šenjug P; Horaček M; Galešić Ljubanović D; Galešić K
Croat Med J; 2022 Aug; 63(4):389-393. PubMed ID: 36046936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
